Annual Accounts Payable
$550.00 M
-$355.00 M-39.23%
31 December 2023
Summary:
Gilead Sciences annual accounts payable is currently $550.00 million, with the most recent change of -$355.00 million (-39.23%) on 31 December 2023. During the last 3 years, it has fallen by -$155.00 million (-21.99%). GILD annual accounts payable is now -58.56% below its all-time high of $1.33 billion, reached on 31 December 2012.GILD Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$903.00 M
+$366.00 M+68.16%
30 September 2024
Summary:
Gilead Sciences quarterly accounts payable is currently $903.00 million, with the most recent change of +$366.00 million (+68.16%) on 30 September 2024. Over the past year, it has increased by +$353.00 million (+64.18%). GILD quarterly accounts payable is now -42.52% below its all-time high of $1.57 billion, reached on 30 June 2015.GILD Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +64.2% |
| 3 y3 years | -22.0% | +28.1% |
| 5 y5 years | -22.9% | +26.6% |
GILD Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.2% | at low | -0.2% | +68.2% |
| 5 y | 5 years | -39.2% | at low | -0.2% | +71.3% |
| alltime | all time | -58.6% | >+9999.0% | -42.5% | >+9999.0% |
Gilead Sciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $903.00 M(+68.2%) |
| June 2024 | - | $537.00 M(-13.7%) |
| Mar 2024 | - | $622.00 M(+13.1%) |
| Dec 2023 | $550.00 M(-39.2%) | $550.00 M(-6.1%) |
| Sept 2023 | - | $586.00 M(-5.8%) |
| June 2023 | - | $622.00 M(-0.8%) |
| Mar 2023 | - | $627.00 M(-30.7%) |
| Dec 2022 | $905.00 M(+28.4%) | $905.00 M(+47.4%) |
| Sept 2022 | - | $614.00 M(+8.7%) |
| June 2022 | - | $565.00 M(-3.1%) |
| Mar 2022 | - | $583.00 M(-17.3%) |
| Dec 2021 | $705.00 M(-16.5%) | $705.00 M(+20.5%) |
| Sept 2021 | - | $585.00 M(-3.8%) |
| June 2021 | - | $608.00 M(+6.7%) |
| Mar 2021 | - | $570.00 M(-32.5%) |
| Dec 2020 | $844.00 M(+18.4%) | $844.00 M(+60.2%) |
| Sept 2020 | - | $527.00 M(-0.9%) |
| June 2020 | - | $532.00 M(-9.8%) |
| Mar 2020 | - | $590.00 M(-17.3%) |
| Dec 2019 | $713.00 M(-9.7%) | $713.00 M(+12.8%) |
| Sept 2019 | - | $632.00 M(+2.4%) |
| June 2019 | - | $617.00 M(+6.9%) |
| Mar 2019 | - | $577.00 M(-27.0%) |
| Dec 2018 | $790.00 M(-2.9%) | $790.00 M(+36.2%) |
| Sept 2018 | - | $580.00 M(-6.9%) |
| June 2018 | - | $623.00 M(-12.4%) |
| Mar 2018 | - | $711.00 M(-12.7%) |
| Dec 2017 | $814.00 M(-32.5%) | $814.00 M(+17.0%) |
| Sept 2017 | - | $696.00 M(-15.0%) |
| June 2017 | - | $819.00 M(-13.2%) |
| Mar 2017 | - | $944.00 M(-21.7%) |
| Dec 2016 | $1.21 B(+2.4%) | $1.21 B(+14.6%) |
| Sept 2016 | - | $1.05 B(-6.2%) |
| June 2016 | - | $1.12 B(+18.7%) |
| Mar 2016 | - | $945.00 M(-19.8%) |
| Dec 2015 | $1.18 B(+23.4%) | $1.18 B(-4.9%) |
| Sept 2015 | - | $1.24 B(-21.1%) |
| June 2015 | - | $1.57 B(+55.4%) |
| Mar 2015 | - | $1.01 B(+5.9%) |
| Dec 2014 | $955.00 M(-24.0%) | $955.00 M(-19.3%) |
| Sept 2014 | - | $1.18 B(+1.8%) |
| June 2014 | - | $1.16 B(-5.8%) |
| Mar 2014 | - | $1.23 B(-1.7%) |
| Dec 2013 | $1.26 B(-5.4%) | $1.26 B(-7.0%) |
| Sept 2013 | - | $1.35 B(-2.9%) |
| June 2013 | - | $1.39 B(+2.5%) |
| Mar 2013 | - | $1.36 B(+2.2%) |
| Dec 2012 | $1.33 B(+10.1%) | $1.33 B(+0.6%) |
| Sept 2012 | - | $1.32 B(-3.5%) |
| June 2012 | - | $1.37 B(+2.1%) |
| Mar 2012 | - | $1.34 B(+11.0%) |
| Dec 2011 | $1.21 B(+50.2%) | $1.21 B(+13.4%) |
| Sept 2011 | - | $1.06 B(-3.5%) |
| June 2011 | - | $1.10 B(+12.3%) |
| Mar 2011 | - | $981.63 M(+22.2%) |
| Dec 2010 | $803.02 M(-0.9%) | $803.02 M(-15.5%) |
| Sept 2010 | - | $950.81 M(-10.8%) |
| June 2010 | - | $1.07 B(+12.4%) |
| Mar 2010 | - | $949.08 M(+17.1%) |
| Dec 2009 | $810.54 M(+34.8%) | $810.54 M(+9.1%) |
| Sept 2009 | - | $742.68 M(+14.3%) |
| June 2009 | - | $650.00 M(+12.4%) |
| Mar 2009 | - | $578.36 M(-3.8%) |
| Dec 2008 | $601.20 M | $601.20 M(-4.8%) |
| Sept 2008 | - | $631.52 M(+4.2%) |
| June 2008 | - | $606.25 M(+53.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $396.21 M(+36.5%) |
| Dec 2007 | $290.33 M(-20.9%) | $290.33 M(+9.8%) |
| Sept 2007 | - | $264.50 M(-0.3%) |
| June 2007 | - | $265.26 M(-10.8%) |
| Mar 2007 | - | $297.27 M(-19.0%) |
| Dec 2006 | $367.03 M(+417.6%) | $367.03 M(+76.6%) |
| Sept 2006 | - | $207.81 M(+35.1%) |
| June 2006 | - | $153.82 M(+155.5%) |
| Mar 2006 | - | $60.21 M(-15.1%) |
| Dec 2005 | $70.91 M(+49.1%) | $70.91 M(+114.0%) |
| Sept 2005 | - | $33.13 M(-42.6%) |
| June 2005 | - | $57.70 M(+60.9%) |
| Mar 2005 | - | $35.86 M(-24.6%) |
| Dec 2004 | $47.55 M(+33.4%) | $47.55 M(+41.7%) |
| Sept 2004 | - | $33.55 M(+11.9%) |
| June 2004 | - | $29.99 M(+6.7%) |
| Mar 2004 | - | $28.11 M(-21.2%) |
| Dec 2003 | $35.65 M(+46.1%) | $35.65 M(+44.4%) |
| Sept 2003 | - | $24.68 M(+4.4%) |
| June 2003 | - | $23.64 M(-1.9%) |
| Mar 2003 | - | $24.10 M(-1.3%) |
| Dec 2002 | $24.41 M(+27.3%) | $24.41 M(+41.5%) |
| Sept 2002 | - | $17.25 M(+38.2%) |
| June 2002 | - | $12.49 M(+31.1%) |
| Mar 2002 | - | $9.53 M(-50.3%) |
| Dec 2001 | $19.17 M(+65.2%) | $19.17 M(+25.6%) |
| Sept 2001 | - | $15.26 M(+25.6%) |
| June 2001 | - | $12.15 M(+22.6%) |
| Mar 2001 | - | $9.91 M(-14.6%) |
| Dec 2000 | $11.61 M(+22.4%) | $11.61 M(+73.1%) |
| Sept 2000 | - | $6.70 M(+43.9%) |
| June 2000 | - | $4.66 M(-29.1%) |
| Mar 2000 | - | $6.57 M(-30.7%) |
| Dec 1999 | $9.48 M(+23.1%) | $9.48 M(-12.2%) |
| Sept 1999 | - | $10.80 M(+200.0%) |
| June 1999 | - | $3.60 M(+2.9%) |
| Mar 1999 | - | $3.50 M(-54.5%) |
| Dec 1998 | $7.70 M(+133.3%) | $7.70 M(+185.2%) |
| Sept 1998 | - | $2.70 M(-27.0%) |
| June 1998 | - | $3.70 M(+5.7%) |
| Mar 1998 | - | $3.50 M(+6.1%) |
| Dec 1997 | $3.30 M(+32.0%) | $3.30 M(+106.3%) |
| Sept 1997 | - | $1.60 M(-30.4%) |
| June 1997 | - | $2.30 M(-34.3%) |
| Mar 1997 | - | $3.50 M(+40.0%) |
| Dec 1996 | $2.50 M(+4.2%) | $2.50 M(+31.6%) |
| Sept 1996 | - | $1.90 M(+72.7%) |
| June 1996 | - | $1.10 M(+37.5%) |
| Mar 1996 | - | $800.00 K(-11.1%) |
| Dec 1995 | $2.40 M(+140.0%) | - |
| Sept 1995 | - | $900.00 K(+28.6%) |
| June 1995 | - | $700.00 K(-30.0%) |
| Mar 1995 | - | $1.00 M(+25.0%) |
| Mar 1995 | $1.00 M(-9.1%) | - |
| Dec 1994 | - | $800.00 K(+33.3%) |
| Sept 1994 | - | $600.00 K(-14.3%) |
| June 1994 | - | $700.00 K(-36.4%) |
| Mar 1994 | $1.10 M(0.0%) | $1.10 M(+22.2%) |
| Dec 1993 | - | $900.00 K(-10.0%) |
| Sept 1993 | - | $1.00 M(+11.1%) |
| June 1993 | - | $900.00 K(-18.2%) |
| Mar 1993 | $1.10 M(+175.0%) | $1.10 M(-8.3%) |
| Dec 1992 | - | $1.20 M(+300.0%) |
| Sept 1992 | - | $300.00 K(-40.0%) |
| June 1992 | - | $500.00 K(+25.0%) |
| Mar 1992 | $400.00 K(+33.3%) | $400.00 K(+33.3%) |
| Mar 1991 | $300.00 K | $300.00 K |
FAQ
- What is Gilead Sciences annual accounts payable?
- What is the all time high annual accounts payable for Gilead Sciences?
- What is Gilead Sciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Gilead Sciences?
- What is Gilead Sciences quarterly accounts payable year-on-year change?
What is Gilead Sciences annual accounts payable?
The current annual accounts payable of GILD is $550.00 M
What is the all time high annual accounts payable for Gilead Sciences?
Gilead Sciences all-time high annual accounts payable is $1.33 B
What is Gilead Sciences quarterly accounts payable?
The current quarterly accounts payable of GILD is $903.00 M
What is the all time high quarterly accounts payable for Gilead Sciences?
Gilead Sciences all-time high quarterly accounts payable is $1.57 B
What is Gilead Sciences quarterly accounts payable year-on-year change?
Over the past year, GILD quarterly accounts payable has changed by +$353.00 M (+64.18%)